Clinical Trials Logo

Critical Illness clinical trials

View clinical trials related to Critical Illness.

Filter by:

NCT ID: NCT04014816 Completed - Constipation Clinical Trials

Gastrointestinal Dysfunction During Enteral Nutrition in Critically Ill Patients

Start date: January 1, 2015
Phase:
Study type: Observational

Gastrointestinal (GI) motility disorders in intensive care patients remain relatively unexplored. Nowadays, the frequency, risk factors and complications of GI dysfunction during enteral nutrition (EN) become more questionable. Our aim is to evaluate the frequency, risk factors and complications of GI dysfunction during EN in the first 2 weeks of the intensive care unit (ICU) stay and to identify precautions to prevent the development of GI dysfunction and avoid complications.

NCT ID: NCT04013893 Recruiting - Critical Illness Clinical Trials

Evaluation of Enteral Nutrition in Critically Ill Children

Start date: June 1, 2019
Phase:
Study type: Observational

The aim of this study was to evaluate the effect of calorie and enteral feeding timing on survival in critically ill children receiving inotropic, vasopressor and inodilatory supplements.

NCT ID: NCT04012333 Withdrawn - Critical Illness Clinical Trials

The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial

EFFORTcombo
Start date: June 2020
Phase: Phase 3
Study type: Interventional

The primary research question: In critically ill patients with nutrition 'risk factors', what is the effect of providing combined EN/PN to the group prescribed a higher dose (≥2.2 grams/kg/day) of protein/amino acid administration compared to a low group prescribed ≤1.2 gram/kg/day (EN only) on patient's functional recovery as measured by 6-minute walk distance just prior to hospital discharge? The hypothesis: Compared to a control group reflective of usual care prescribing practices and an EN only approach, the administration of a higher dose protein/amino acids using EN and PN to nutritionally high-risk critically ill patients will be associated with improved functional outcome.

NCT ID: NCT04005300 Recruiting - Critical Illness Clinical Trials

Application of Prophylactic Low Calorie Feeding in Critically Ill Patients With High-risk Refeeding Syndrome

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Critically ill patients with high-risk nutrition are often at risk of refeeding syndrome(RFS), that the incidence of RFS is as high as 30-50%. It is sure that patients with refeeding syndrome were treated with restrictive enteral nutrition, but the definition of refeeding syndrome is not uniform, and there is still a lack of awareness high-risk patients of RFS to receiving early empirical low-calorie feeding intervention. So, we designed the study which is divided into three stages. Firstly, the monitoring rate of RFS was reviewed to evaluate the incidence of RFS in general ICU. Secondly, the best diagnostic criteria of RFS were prospectively defined. Finally, on this basis, it is assessed whether early low-calorie feeding could improve prognosis in high-risk patients with RFS.

NCT ID: NCT03997929 Completed - Critically Ill Clinical Trials

Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients (pBDG2)

pBDG2
Start date: January 20, 2020
Phase:
Study type: Observational [Patient Registry]

New rapid diagnostic strategies are warranted in intra-abdominal candidiasis (IAC). A previous retrospective study showed that one measure, the day of the surgery, of peritoneal 1.3-Beta-D-Glucan ≤ 310pg/ml could rule out an IAC. This strategy was independent of the patient underlying conditions and Candida risk factors. This study aimed to confirm these results with a multicenter prospective study

NCT ID: NCT03992716 Terminated - Critical Illness Clinical Trials

Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness

Start date: November 26, 2019
Phase: Phase 4
Study type: Interventional

The main focus of the study is to show that SmofKabiven® extra Nitrogen, in a realistic clinical setting, enables to meet high protein requirements in patients during the first week after onset of critical illness, without risk of overfeeding with energy.

NCT ID: NCT03991611 Active, not recruiting - Critical Illness Clinical Trials

Reducing Post-traumatic Stress Disorder After ICU Discharge With the IPREA3 Program

PTSD-REA
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Reducing discomfort in the intensive care unit (ICU) should be beneficial to longterm outcomes. This study assesses whether a tailored multicomponent program for discomfort reduction may be effective in reducing post-traumatic stress disorder (PTSD) symptoms at 1-year in general ICU survivors. The psychiatric morbidity may be increased by the COVID-19 epidemic and its consequences on the healthcare system (patient care, reorganization of French ICUs). The main objective of PTSD-REA_COVID cohort is to assess this psychiatric morbidity 6 months after an ICU stay during the epidemic period.

NCT ID: NCT03982628 Not yet recruiting - Sepsis Clinical Trials

ICU Sarcopenia Rates by Abdominal CT: Sepsis vs. Trauma

Start date: August 1, 2020
Phase:
Study type: Observational

Using abdominal computed tomography (CT) imaging, the investigators will estimate total body muscle mass at two time points in Intensive Care Unit (ICU) by assessing cross-sectional muscle areas at the L3 vertebral body level. This allows for a determination of the rate of sarcopenia development in the ICU. With this information, the investigators propose to test if the rates of the development of sarcopenia differ in critically ill subjects with sepsis compared to a reference group of critically ill subjects with trauma (without sepsis).

NCT ID: NCT03972384 Completed - Critical Illness Clinical Trials

A Problem Solving Intervention for Post-ICU Cognitive Impairment in Older Adults

PIC-UPS
Start date: January 21, 2022
Phase: N/A
Study type: Interventional

This study will apply an evidence based program to assist ICU survivors to overcome cognitive problems as a result of their critical illness. This study will determine feasibility of recruitment, retention and engagement with the program as well as acceptability of the program to the participants.

NCT ID: NCT03969966 Recruiting - Critical Illness Clinical Trials

Citrate Anticoagulation for Postdilution Hemofiltration

CIPOHA
Start date: January 14, 2019
Phase:
Study type: Observational

This study evaluates a protocol for regional citrate anticoagulation in critically ill patients with acute kidney injury who are treated with continuous veno-venous haemofiltration in postdilution mode.